Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

Tekijä Homar, Francesc, Lozano, Virginia, Martínez-Gómez, Juan, Oyagüez, Itziar, Pareja, Antonio, Payeras, Antoni, Serrano, Joaquín, Carratalá, Carmen, Casado, Miguel Ángel
Julkaistu 2012